- Home
- SGRP vs LGVN Comparison
SGRP vs LGVN Comparison
Compare SGRP & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRP
- LGVN
- Stock Information
- Founded
- SGRP 1967
- LGVN 2014
- Country
- SGRP United States
- LGVN United States
- Employees
- SGRP N/A
- LGVN N/A
- Industry
- SGRP Business Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- SGRP Consumer Discretionary
- LGVN Health Care
- Exchange
- SGRP Nasdaq
- LGVN Nasdaq
- Market Cap
- SGRP 24.5M
- LGVN 23.4M
- IPO Year
- SGRP 1996
- LGVN 2021
- Fundamental
- Price
- SGRP $1.15
- LGVN $1.67
- Analyst Decision
- SGRP
- LGVN Strong Buy
- Analyst Count
- SGRP 0
- LGVN 3
- Target Price
- SGRP N/A
- LGVN $8.67
- AVG Volume (30 Days)
- SGRP 103.9K
- LGVN 825.0K
- Earning Date
- SGRP 07-17-2025
- LGVN 08-13-2025
- Dividend Yield
- SGRP N/A
- LGVN N/A
- EPS Growth
- SGRP N/A
- LGVN N/A
- EPS
- SGRP N/A
- LGVN N/A
- Revenue
- SGRP $148,274,000.00
- LGVN $2,225,000.00
- Revenue This Year
- SGRP N/A
- LGVN N/A
- Revenue Next Year
- SGRP N/A
- LGVN $51.48
- P/E Ratio
- SGRP N/A
- LGVN N/A
- Revenue Growth
- SGRP N/A
- LGVN 127.50
- 52 Week Low
- SGRP $0.91
- LGVN $1.14
- 52 Week High
- SGRP $2.48
- LGVN $4.29
- Technical
- Relative Strength Index (RSI)
- SGRP 61.68
- LGVN 63.06
- Support Level
- SGRP $1.10
- LGVN $1.43
- Resistance Level
- SGRP $1.25
- LGVN $1.80
- Average True Range (ATR)
- SGRP 0.06
- LGVN 0.15
- MACD
- SGRP 0.02
- LGVN 0.02
- Stochastic Oscillator
- SGRP 70.56
- LGVN 72.92
About SGRP SPAR Group Inc.
SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.